INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Mar 10, 2020 |
Director, President and Chief Scientific
|
Director, President and Chief Scientific | Form 4 | Open market or private sale of non-derivative or derivative security | 7 | $486.31 | 517,799 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 7 | $16.87 | 66,819 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 7 | $17.04 | 66,510 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 9 | $16.88 | 66,810 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 11 | $17.00 | 66,631 |
| Jan 09, 2006 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 16 | $17.52 | 66,412 |
| Jan 09, 2004 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 17 | $15.60 | 64,749 |
| Jan 09, 2004 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 17 | $15.53 | 64,681 |
| Jan 09, 2004 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 17 | $15.48 | 64,664 |
| Jan 09, 2004 |
Director, EVP, CSO, & Pres Regn Res Labs
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 17 | $15.47 | 64,647 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.